Literature DB >> 12798632

Optimization of epicutaneous immunization for the induction of CTL.

Roopjeet Kahlon1, Yuxiang Hu, Catherine H Orteu, Arnawaz Kifayet, Jacqueline D Trudeau, Rusung Tan, Jan P Dutz.   

Abstract

The immune system of the skin has recently been exploited for the development of non-invasive vaccine technologies. However, one of the limitations of current vaccine protocols is the inefficient priming of cytotoxic T lymphocytes (CTL). In this study, we report that the application of either an immunodominant class I MHC restricted ovalbumin peptide or whole ovalbumin protein, to tape-stripped skin together with the co-application of the bacterial enterotoxin cholera toxin (CT) induces antigen-specific CTL. Tape-stripping (TS) was found to enhance the magnitude of antibody responses to co-administered protein and to promote the generation of antigen-specific IgG(2a) responses. As well, both cholera toxin and tape-stripping enhanced epidermal dendritic cell (DC) immigration into draining lymph nodes. The adjuvant effect of co-administered cholera toxin and tape-stripping in promoting CTL priming was not dependent on IL-12. Epicutaneous immunization has previously been shown to induce robust antibody responses to administered protein antigen. We now demonstrate the induction of robust and persistent CTL responses to epicutaneously administered protein antigen. Epicutaneous immunization is cheap, simple and effective. These findings suggest the potential use of the skin for the generation of protective immune responses to both viral and tumor challenge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798632     DOI: 10.1016/s0264-410x(03)00141-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

Authors:  Igor M Belyakov; Scott A Hammond; Jeffrey D Ahlers; Gregory M Glenn; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination.

Authors:  Irlanda Olvera-Gomez; Sara E Hamilton; Zhengguo Xiao; Carla P Guimaraes; Hidde L Ploegh; Kristin A Hogquist; Liangchun Wang; Stephen C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 3.  Adjuvants for human vaccines.

Authors:  Carl R Alving; Kristina K Peachman; Mangala Rao; Steven G Reed
Journal:  Curr Opin Immunol       Date:  2012-04-19       Impact factor: 7.486

4.  Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice.

Authors:  Tsuyoshi Itoh; Esteban Celis
Journal:  J Immunother       Date:  2005 Sep-Oct       Impact factor: 4.456

5.  Immunological activation following transcutaneous delivery of HR-gp100 protein.

Authors:  Shoshana Frankenburg; Igor Grinberg; Ziva Bazak; Lena Fingerut; Jacob Pitcovski; Raphael Gorodetsky; Tamar Peretz; Ram M Spira; Yehuda Skornik; Ronald S Goldstein
Journal:  Vaccine       Date:  2007-04-25       Impact factor: 3.641

6.  Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.

Authors:  Gaëlle Vandermeulen; Liévin Daugimont; Hervé Richiardi; Marie-Lise Vanderhaeghen; Nathalie Lecouturier; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

Review 7.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

8.  A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations.

Authors:  Espen S Baekkevold; Marc-André Wurbel; Pia Kivisäkk; Clare M Wain; Christine A Power; Guttorm Haraldsen; James J Campbell
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

9.  Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Authors:  Wing Ki Cheng; Kathleen Wee; Tobias R Kollmann; Jan P Dutz
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

10.  Langerhans cells cross-present antigen derived from skin.

Authors:  Patrizia Stoitzner; Christoph H Tripp; Andreas Eberhart; Kylie M Price; Jae Y Jung; Laura Bursch; Franca Ronchese; Nikolaus Romani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.